Prognostic Implications of Point-of-Care and Serial B-type Natriuretic Peptide Levels in Patients With Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HC) is a heterogeneous disease with a variable clinical course. Predictors of long-term adverse cardiovascular events are needed. Our objectives were to determine the long term prognostic value of a single and serial point of care (POC) B-type natriuretic-peptide (BNP) measurements in HC. One hundred and eleven ambulatory patients with HC (mean age 53 ±16years) were prospectively recruited over a 2-year period (2004-2006). A clinical assessment, comprehensive echocardiogram, and a POC BNP level was obtained at baseline and at a 1-2 year follow-up.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research